ClearPoint Neuro, Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2012

Dec. 31, 2011

Impact of Conversions to Common Stock [Table Text Block]

	Impact to Balance Sheet								Increase in
	Before Conversions		Impact of Conversions			After Conversions			Common Shares Outstanding

Impact on assets
Deferred costs	$	799,123	$	(799,123	)	$	-			-

Impact on liabilities and equity
Accrued interest on converted notes	$	974,311	$	(974,311	)	$	-			1,092,559
Summer 2011 Notes, net		904,397		(904,397	)		-			2,183,334
March 2010 Notes, net		4,057,500		(4,057,500	)		-			4,071,000
2011 Unit Offering Notes, net		4,367,482		(4,367,482	)		-			9,050,834
Total impact on liabilities		10,303,690		(10,303,690	)		-			16,397,727
Series A convertible preferred stock		7,965,000		(7,965,000	)		-			7,965,000
Additional paid-in capital and common stock		-		19,345,209			19,345,209			-
Accumulated deficit		-		(1,875,642	)		(1,875,642	)		-
Total impact on equity		7,965,000		9,504,567			17,469,567			7,965,000
Total impact on liabilities and equity	$	18,268,690	$	(799,123	)	$	17,469,567			24,362,727

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

	Shares			Weighted - Average Exercise Price
Outstanding, January 1, 2012		3,679,977		$	2.05
Granted		2,797,400			1.02
Exercised, including 16,000 shares withheld on net settled exercises		(30,000	)		1.80
Forfeited		(315,250	)		2.16
Outstanding, September 30, 2012		6,132,127			1.58

	Options Outstanding			Options Exercisable		Range of Exercise Prices					Weighted- average Exercise price per share		Intrinsic Value (1)
Balance at January 1, 2009		599,875				$	0.88	-	$	24.00	$	3.62	$	3,742,700
Options exercisable at January 1, 2009					432,083		0.88	-		24.00		2.70		3,133,667
Options granted (2)		93,402						9.64				9.64
Options exercised		(3,333	)					3.20				3.20
Options cancelled or forfeited		(20,167	)				1.64	-		20.00		9.60
Balance at December 31, 2009		669,777					0.88	-		24.00		4.28		3,694,400
Options exercisable at December 31, 2009					483,364		0.88	-		24.00		2.78		3,424,333
Options granted (2)		3,246,450						1.80				1.80
Options cancelled or forfeited		(153,750	)				3.20	-		24.00
Outstanding at December 31, 2010		3,762,477					0.88	-		24.00		2.11		262,500
Options exercisable at December 31, 2010					433,746		0.88	-		24.00		3.03		262,500
Options cancelled or forfeited		(82,500	)				1.80	-		24.00		4.93
Outstanding at December 31, 2011		3,679,977					0.88	-		9.64		2.05		—
Options exercisable at December 31, 2011					1,501,659		0.88	-		9.64		2.15		—

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

Dividend yield		0%
Expected Volatility		45.2%
Risk free Interest rates	0.83%	-	1.13%
Expected lives (years)		6.0

	Year Ended December 31,
	2010	2009
Dividend yield	0%		0%
Expected Volatility	44.81%	23.45%	to	38.28%
Risk free Interest rates	2.36%	1.48%	to	2.43%
Expected lives (years)	6.0	3.25	to	5.75

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

	Three Months Ended September 30,			Nine Months Ended September 30,
	2012	2011		2012		2011
$	299,083	$	248,540	$	842,645	$	757,200

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

	Shares			Weighted - Average Exercise Price
Outstanding, January 1, 2012		1,922,944		$	0.43
Issued		7,607,071			1.05
Exercised, including 158,078 shares withheld on net settled exercises		(584,768	)		0.69
Outstanding, September 30, 2012		8,945,247			0.94

				Weighted -
				Average
				Exercise
	Shares			Price
Warrants outstanding at January 1, 2009		828,502		$	1.74

Warrants that expired during 2009		(417,960	)		0.04

Warrants outstanding at December 31, 2009		410,542			0.42

Warrants issued during 2010		25,444			8.00

Warrants outstanding at December 31, 2010		435,986			3.74

Warrants that expired during 2011		(410,542	)		3.48

Warrants issued during 2011		2,122,500			0.29

Warrants exercised during 2011		(225,000	)		0.01

Warrants outstanding at December 31, 2011		1,922,944			0.43

Assumptions Used in Calculating Fair Value of Warrants Issued [Table Text Block]

Dividend yield		0%
Expected Volatility	41.3%	-	49.0%
Risk free Interest rates	0.19%	-	0.93%
Expected lives (years)	1.7	-	5.0

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]

				Options Outstanding						Options Exercisable
Range of Exercise Prices				Number Outstanding		Weighted - Average Remaining Contractual Life		Weighted - Average Exercise Price		Number Exercisable		Weighted - Average Exercise Price
$	0.88	-	0.96		287,500		2.33	$	0.89		287,500	$	0.89
		1.80			3,195,950		8.96		1.80		1,065,318		1.80
	3.20	-	9.64		196,527		4.75		7.74		148,841		7.13
					3,679,977		8.21		2.05		1,501,659		2.15

Schedule of Nonvested Share Activity [Table Text Block]

Nonvested Stock Options	Shares			Weighted - Average Grant Date Fair Value
Nonvested January 1, 2009		167,792		$	1.67
Granted		93,402			2.83
Forfeited/cancelled		(7,250	)		2.84
Vested		(67,531	)		1.11
Nonvested December 31, 2009		186,413			2.41

Granted		3,246,450			0.83
Forfeited		(41,667	)		1.92
Vested		(62,465	)		2.31
Nonvested December 31, 2010		3,328,731			0.88

Forfeited		(51,833	)		0.88
Vested		(1,098,580	)		0.89
Nonvested December 31, 2011		2,178,318			0.87

Schedule of Share-based Payment Award, Warrants, Valuation Assumptions [Table Text Block]

	Year Ended December 31,
	2011			2010
Dividend yield		0%		0%
Expected Volatility	48.67%	to	49.36%	44.81%
Risk free Interest rates	0.81%	to	1.13%	2.36%
Expected lives (years)		5.0		5.0

- Definition

Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.

+ References + Details

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details